GENE ONLINE|News &
Opinion
Blog

PARP Inhibitor
Regulatory PARP Inhibitor
EMA Recommends Restriction on Rubraca
2022-07-25
Trials & Approvals PARP Inhibitor
AZ, Merck’s PARP Inhibitor Shines in Phase 3 Prostate Cancer Trial
2021-09-26
China
Zai Lab, Schrödinger Collaborate to Advance Cancer Program
2021-08-05
Trials & Approvals
Clovis Oncology’s PARP Inhibitor Shines in Preliminary Prostate Cancer Trial
2021-04-12
Technology
Understanding Cancer Chromosomal Instability: Highlights from the AACR2021 Discovery Science Plenary Session
2021-04-11
Trials & Approvals PARP Inhibitor
Lynparza Bags Multiple Approvals in Japan
2021-01-05
In-Depth
Tumor Drug Resistance Helps Identify a Novel Therapy for Leukemia
2020-10-11
Trials & Approvals
#ESMO20: AZ, Merck’s PARP Inhibitor Surpasses Standard of Care in Prostate Cancer Trial
2020-09-22
Trials & Approvals Pancreatic Cancer
Lynparza Notches EU Authorization for BRCA-Mutated Metastatic Pancreatic Cancer
2020-07-11
Trials & Approvals Prostate Cancer
Lynparza Greenlighted by FDA for HRR-Mutated, Metastatic Prostate Cancer
2020-05-27
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
Technology
AACR 2020 Conference – Opening Clinical Plenary Highlights
2020-04-28
In-Depth Drug Resistance
Cancer Drug Resistance: Implications in Cancer Therapy
2020-04-20
COVID-19 PARP Inhibitor
Genentech’s Actemra gets FDA approval to begin COVID-19 Trials in April
2020-03-25
Licensing PARP Inhibitor
Japan Grants Orphan Drug Designation to Lynparza for Germline BRCA-mutated Pancreatic Cancer
2020-03-25
1 2
LATEST
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
Rice University Engineers Develop Miniature Brain Stimulator for Safer and Less-invasive Neuromodulation
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top